• Japanese
  • Korean
  • Chinese
Cover Image

Immunoassay Systems

Abstract

This report analyzes the worldwide markets for Immunoassay Systems in US$ Million by the following Product Segments (includes Immunoassay Analyzers and Reagents) - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems. The report provides separate comprehensive analytics for the US, Canada, Japan Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 65 companies including many key and niche players such as Abbott Laboratories, Beckman Coulter Inc., bioMerieux, Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., Roche Diagnostics, and Siemens Healthcare Diagnostics. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

About Global Industry Analysts, Inc.

Global Industry Analysts, Inc. (GIA) is a reputed publisher of off-the-shelf market research. Recognized as one of the most consistently accurate forecasting company in the world, GIA currently serves more than 9,500 companies from 36 countries worldwide. The company was founded in 1987, initially recognized globally as a research boutique specializing in the medical industry. Over the past 25 years, the company expanded its coverage and now publishes extensively upon more than 180 major industries.

Our experienced team is dedicated to world-class research and analysis. We attribute our success to our people, their commitment and work culture.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • Enzyme Immunoassay
    • Fluorescence Immunoassay
    • Chemiluminescence Immunoassay
    • Radioimmunoassay
    • Nephelometric Immunoassay

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • In-Vitro Diagnostics - A Rudimentary Overview
  • Technologies Used in IVD
  • Market Structure
  • Factors Influencing IVD Industry: On a Scale of 1-5
  • Key Statistical Findings:
    • Table 1: World In-Vitro Diagnostic Products Market by End-Use Segment (2011) - Percentage Breakdown by Value Sales for Hospital Labs, Commercial Labs, Self-Testing and POC (includes corresponding Graph/Chart)
    • Table 2: Global IVD Market (2011): Percentage Share Breakdown of Value Sales by Country/Region (includes corresponding Graph/Chart)
    • Competition in the IVD Market
    • Table 3: Global IVD Market (2011): Percentage Market Share Breakdown of Leading Players (includes corresponding Graph/Chart)
  • Immunoassays - A Key Component in the IVD Market
  • Waxing Importance of Immunoassays in the Overall Diagnostic Test Market
  • Innovation - Name of the Game
    • Novel Biomarkers & Advanced Technologies to Boost Market
  • Expanding Immunoassay Applications Boost Demand for Immunoassay Systems
    • Table 4: Global Laboratory Based Immunoassay Market (2011): Percentage Share Breakdown of Value Sales by Analyte Type (includes corresponding Graph/Chart)
    • Table 5: World Immunoassay Market by End-Use Industry (2011): Percentage Breakdown by Value Sales for Clinical, Food and Environment Industries (includes corresponding Graph/Chart)
    • Increasing Use of Immunoassays in Food Sciences and Quality Control
    • Immunoassay Techniques for Testing Environmental Samples Makes a Mark
    • Application of Immunoassays for Trace Methodology
  • Outlook
    • Developing Markets to Turbo Charge Growth in the Market
    • Table 6: Worldwide Immunoassay Systems Market (2011) - Percentage Share Breakdown of Value Sales by Leading Players (includes corresponding Graph/Chart)

2. INDUSTRY TRENDS & ISSUES

  • Impact of the 2007-2009 Recession in Retrospect
  • The Future of Immunoassays in a Rationing Healthcare System in Europe
  • Market for Adjunctive Therapies to Grow Fast
  • Hospital and Laboratory Consolidations Drive the Market for Immunoassay Products
  • Advancement in Genetic Research Drives the Growth
  • Emerging Assays to Make the Cut
  • Shift Towards Point-of-Care Test Systems
  • Introduction of Portable Immunoassay Systems Energizes the Market
  • Increasing Demand for Random Access Immunoanalyzers.....
  • Task-Targeted Automated Chemiluminescent Assays to Penetrate
  • Changing Scene for Immunodiagnostic Testing...
  • Laboratory Automation on Rise
  • Implications for Immunoassay Market
  • Challenges Stifle Bio-Marker Research
  • Radioimmunoassay Systems Lose Sheen Despite Being a Reliable IVD Diagnostic Platform
  • Instrument Rental - A Boon or a Bane?
  • Immunochemistry Analyzers: Gaining Traction

3. CONCEPTUAL OVERVIEW

  • Immunoassays - Definition and Description....
  • Down the Timeline
  • Immunoassay Analyzers
  • Immunoassay Reagents
  • Radioimmunoassay
  • Non-Isotopic Immunoassays
  • Customized Immunoassays
  • Demerits of Immunoassays
  • Labels - Necessary for Detection
  • Select End-Use Applications of Immunoassays
  • Infectious Disease
  • Endocrine Testing Procedures
  • Blood Processing Market
  • Cancer Testing Markets
  • Drugs of Abuse Testing Market
  • Therapeutic Drug Monitoring
  • Immune Disease
  • Blood Grouping and Typing
  • Components of Immunoassays
  • Signal Response
  • Labeled Tracer
  • Binder
  • Buffer Matrix
  • Incubation Conditions
  • Separation Process
  • Standard Specimens
  • Control Specimens
  • Unknown Specimens
  • Chemiluminescent Substrates - Growing Appeal
  • Radioimmunoassay Analyzers, Gamma Counters
  • Fundamentals of Operation
  • Problems Involved
  • Enzyme Immunoassay Analyzers, Fluorescence Immunoassay Analyzers and Chemiluminescence's Immunoassay Analyzers
  • Enzyme Immunoassays
  • Automation Enabled
  • Customization of Assays
  • ELISA - A Flexible Enzyme Immunoassay Test.....
    • Constituents of ELISA
      • Working
      • Binding the Antigen and Antibody
      • Conjugate Binding
      • Evidence of Binding
  • Fluorescence Immunoassay - Operating Principle
    • Light Sources
    • Sample Cell
    • Filters
    • Detector
    • Time-Resolved Fluoroimmunoassay
  • Chemiluminescence Immunoassay
  • Types of Immunoassay Techniques
    • Fluorescence Polarization Immunoassay
    • Radiative Energy Attenuation (REA)
    • Substrate-Labeled Fluorescence
    • Enzyme Immunoassay with Fluorescence Detection
    • Solid-Phase Microsphere Immunoassay
    • Microparticle Enzyme Immunoassay (MEIA)
    • Enzyme-Linked Fluorescence Immunoassay
    • ELISA With Photometric Detection
    • Dry-Phase Techniques
      • Sandwich Technique
      • Competitive Binding
      • Reversible Complex Formation
  • The Phase of Development
  • Problems and Limitations....
  • Purchase Considerations.....
  • Cost Considerations....
  • Nephelometric Immunoassay
  • Nephelometry
  • Types of Scatter......
    • Rayleigh Scatter
    • Mie Scatter
    • Rayleigh-Debye Scatter
  • Key Components of Nephelometric Immunoassay Analyzers....
    • Light Sources
    • Detectors
  • Automated Nephelometers....
  • Modes of Operation....
  • Nephelometric Immunoassay Procedures....
  • Associated Problems......
  • Purchase Considerations....
    • Test Menu
    • Analytical Range
    • Linearity
    • Specificity
    • Precision
    • Stability
    • Carryover
    • Downtime
    • Upgrading / Interfacing
    • Reagents
    • Additional Features.....
  • Competing Technologies
  • Mature Technologies.....
    • Cell Counting
    • Clinical Chemistry
    • Microbiology
  • Emerging Technologies......
    • DNA Probes
    • Miniaturization and Microchip Fabrication
    • Blood Glucose Testing
    • Immunohistochemistry (IHC)
    • Non-Invasive Technology
    • Image Analysis and Pattern Recognition
    • Rapidly Growing Molecular Diagnostics
  • New Technologies
    • High-Definition Cell Assay Technologies:
      • (1) Rapid, High-Definition Assays for Cellular Efficacy (RHACE)
      • (2) Single-Cell Analysis of Physiological Effects (SAPhE)
      • (3) Matrix Analysis of Genomically-Indexed Cells (MAGIC)

4. PRODUCT LAUNCHES

  • Bio-Rad Laboratories Unveils Bio-Plex Pro™ Immunoassays
  • Bio-Rad Laboratories Launches Bio-Plex Data Pro™ Software
  • Bio-Rad Laboratories Unveils Bio-Plex Pro™ Magnetic Bead-based Multiplex Immunoassays
  • Roche Diagnostics Unveils Full Range of STAT Immunoassays
  • Siemens Healthcare Diagnostics Unveils VersaCell™ Solution to Streamline Workflow
  • Siemens Healthcare Diagnostics Introduces HIV Combo Assay ADVIA Systems
  • Roche Introduces Roche Cardiac 200
  • Bio-Rad Introduces Bio-Plex Pro™
  • IDS Introduces IDS-iSYS hGH
  • IDS Introduces IDS-iSYS PINP
  • IDS Introduces IDS-iSYS & IDS-iSYS Vitamin D Assay
  • Abbott Introduces ARCHITECT c4000 Clinical Chemistry Analyzer
  • Siemens Introduces Clinical Laboratory Automation Solutions
  • Ortho-Clinical Diagnostics Introduces New Laboratory System
  • Cell Biosciences Launches Kit for Analysis of Oncoproteins
  • Roche Diagnostics Introduces Pre-Eclampsia In-Vitro Tests across Europe
  • Abbott To Launch New ARCHITECT® ci4100™ Integrated Immunoassay & Clinical Chemistry System
  • Abbott Introduces ARCHITECT® i1000SR® Immunochemistry Analyzer
  • Ortho Clinical Diagnostics Unveils Vitros® 3600 Immunodiagnostic System and Vitros® 5600 Integrated System
  • PerkinElmer Releases New AplhaLISA™ Immunoassay Diagnostic Kits
  • Assay Designs Introduces ImmunoSet™ ELISA Development Kit
  • Trinity Biotech Introduces New Lyme Enzyme Diagnostic Products for European Markets (Europe)
  • bioMerieux Introduces VIDAS® NT-proBNP
  • Beckman Coulter Introduces UniCel DxC 880i Synchron® Access®
  • Beckman Coulter Introduces UniCel® DxI 600
  • bioMerieux Introduces VIDAS® B*R*A*H*M*S PCT® Assay
  • Siemens Rolls Out ADVIA Centaur® Cyclosporine (CsA) Assay
  • Ortho-Clinical Diagnostics Launches VITROS Troponin I ES Assay
  • Ortho-Clinical Diagnostics Introduces VITROS® Rubella IgG Assay

5. RECENT INDUSTRY ACTIVITY

  • Beckman Coulter Obtains FDA 510(k) Clearance for AU5800 Chemistry Systems
  • bioMerieux Takes Over ARGENE to Expand Molecular Diagnostic Offerings
  • Roche Files 510 (k) Clearance for Elecsys Analyzers and Cobas Immunoassay
  • Siemens Obtains FDA Clearance for Immulite 2000 XPi
  • Roche Bags Premarket Approval from FDA for Anti-HBc IgM Assay
  • Beckman Coulter Signs Strategic Agreement with Trillium Diagnostics to Market Flow Cytometry Offerings
  • bioMerieux Inks Agreement with Biocartis to Develop Assays
  • bioMerieux Acquvires Meikang Biotech
  • Bio-Rad Purchases Biotest AG's Diagnostics Businesses
  • Immunodiagnostic Systems Receives FDA Approval for IDS-iSYS Immunoassay Analyzer
  • Roche Diagnostics Receives Immunoassay Contract from Premier Purchasing Partner
  • Ortho Clinical Gets US FDA Approval for Usage of VITROS® Hepatitis B Surface Antigen (HBsAG) on VITROS® 5600 Integrated & VITROS® 3600
  • Neogen Takes Over International Diagnostic Systems
  • eBioscience Acquires Bender MedSystems
  • Inverness to Acquire ACON's Lateral Flow Immunoassay Diagnostics Business
  • Beckman Coulter to Purchase Olympus Corp's Diagnostics Division
  • Instrumentation Laboratory Secures FDA Approval for ACL AcuStarTM Hemostasis Testing System
  • Abbott Receives FDA Premarket Approval for ARCHITECT CORE
  • Ivax Diagnostics Inks Distribution Deal with Lin-Zhi International
  • Axis-Shield Inks Distribution Deals for Marketing Afinion
  • bioMerieux and Shanghai Kehua Set Up JV
  • bioMerieux and Quidel to Form Global Alliance for Rapid Diagnostics
  • Johnson & Johnson Nordic AB Takes Over Amic
  • Roche Acquires Ventana Medical Systems, Inc.
  • Abbott Terminates Sale Agreement with GE
  • Abbott Inks Agreement with Premier, Inc.
  • Beckman Coulter Renews Agreement with MedAssets
  • Beckman Coulter Extends Agreement Amerinet
  • Beckman Coulter Extends Partnership with Bio-Rad
  • Siemens Acquires Dade Behring
  • Roche Acquires BioVeris
  • Siemens Healthcare Diagnostics Inks Agreement with Amerinet
  • Siemens Healthcare Diagnostics Signs Agreement with Bio-Rad
  • Siemens Medical Solutions USA Sets Up Siemens Healthcare Diagnostics

6. FOCUS ON SELECT MARKET PARTICIPANTS

  • Abbott Laboratories (US)
  • Beckman Coulter Inc. (US)
  • bioMerieux (France)
  • Bio-Rad Laboratories Inc. (US)
  • Ortho-Clinical Diagnostics Inc (US)
  • Roche Diagnostics (US)
  • Siemens Healthcare Diagnostics (US)

7. GLOBAL MARKET PERSPECTIVE

    • Table 7: World Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 8: World Historic Review for Immunoassay Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 9: World 15-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
  • Immunoassay Systems Market by Product Segment
    • Table 10: World Recent Past, Current & Future Analysis for Enzyme Immunoassay Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 11: World Historic Review for Enzyme Immunoassay Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 12: World 15-Year Perspective for Enzyme Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
    • Table 13: World Recent Past, Current & Future Analysis for Fluorescence Immunoassay Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 14: World Historic Review for Fluorescence Immunoassay Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 15: World 15-Year Perspective for Fluorescence Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
    • Table 16: World Recent Past, Current & Future Analysis for Chemiluminescence Immunoassay Systems by Geographic Region - US, Canada, Japan, Europe,Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 17: World Historic Review for Chemiluminescence Immunoassay Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 18: World 15-Year Perspective for Chemiluminescence Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
    • Table 19: World Recent Past, Current & Future Analysis for Radio Immunoassay Systems & Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 20: World Historic Review for Radio Immunoassay Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 21: World 15-Year Perspective for Radio Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
    • Table 22: World Recent Past, Current & Future Analysis for Nephelometric Immunoassay Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 23: World Historic Review for Nephelometric Immunoassay Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 24: World 15-Year Perspective for Nephelometric Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current and Future Analysis
    • US In-Vitro Diagnostics Market - A Special Review
      • Evolving Trends to Benefit IVD Market
      • Key Statistics
    • Table 25: US In-Vitro Diagnostics (IVD) Market (2011): Percentage Share Breakdown of Revenue by Leading Players (includes corresponding Graph/Chart)
    • US Market for Clinical Laboratory Instruments
      • Laboratory Consolidation and Automation on a Rise
    • Product Launches
    • Strategic Corporate Developments
    • Focus on Select Players
      • Abbott Laboratories
      • Beckman Coulter
      • Bio-Rad Laboratories Inc.
      • Ortho-Clinical Diagnostics Inc
      • Roche Diagnostics
      • Siemens Healthcare Diagnostics
  • B. Market Analytics
    • Table 26: US Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 27: US Historic Review for Immunoassay Systems by Product Segment - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 28: US 15-Year Perspective for Immunoassay Systems by Product Segment - Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

2. CANADA

  • Market Analysis
    • Table 29: Canadian Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 30: Canadian Historic Review for Immunoassay Systems by Product Segment - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 31: Canadian 15-Year Perspective for Immunoassay Systems by Product Segment - Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Outlook
    • Strategic Corporate Development
    • Focus on Key Players
      • Fujirebio Inc
      • Tosoh Corporation
  • B. Market Analytics
    • Table 32: Japanese Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 33: Japanese Historic Review for Immunoassay Systems by Product Segment - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 34: Japanese 15-Year Perspective for Immunoassay Systems by Product Segment - Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analytics
    • Current & Future Analysis
    • Overview of Immunochemistry Analyzer Market in Europe
      • High Switching Costs and Restricted Hospital Budgets Inhibit Market Expansion
    • Panorama of the European Immunoassay Market
    • Challenges
      • Decreasing Profitability
    • Immunodiagnostic Products Market - A Focus
      • Trends in Immunodiagnostic Market.....
    • Product Launches
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 35: European Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region - France, Germany, Italy, the UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 36: European Historic Review for Immunoassay Systems by Geographic Region - France, Germany, Italy, the UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 37: European Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 38: European Historic Review for Immunoassay Systems by Product Segment - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 39: European 15-Year Perspective for Immunoassay Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, the UK, Spain and Rest of Europe Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart)
    • Table 40: European 15-Year Perspective for Immunoassay Systems by Product Segment - Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for Years (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Development
    • bioMerieux - A Key Player
  • B. Market Analytics
    • Table 41: French Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 42: French Historic Review for Immunoassay Systems by Product Segment - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 43: French 15-Year Perspective for Immunoassay Systems by Product Segment - Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current & Future Analysis
    • In-Vitro Diagnostics Market - A Snapshot
  • B. Market Analytics
    • Table 44: German Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 45: German Historic Review for Immunoassay Systems by Product Segment - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 46: German 15-Year Perspective for Immunoassay Systems by Product Segment - Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 47: Italian Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 48: Italian Historic Review for Immunoassay Systems by Product Segment - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 49: Italian 15-Year Perspective for Immunoassay Systems by Product Segment - Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current & Future Analysis
    • IDS - A Key Player in the UK
    • Product Launches
  • B. Market Analytics
    • Table 50: UK Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 51: UK Historic Review for Immunoassay Systems by Product Segment - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 52: UK 15-Year Perspective for Immunoassay Systems by Product Segment - Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4e. SPAIN

  • A. Market Analysis
    • Current & Future Analysis
  • B. Market Analytics
    • Table 53: Spain Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 54: Spain Historic Review for Immunoassay Systems byProduct Segment - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 55: Spain 15-Year Perspective for Immunoassay Systems by Product Segment - Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

4f. REST OF EUROPE

  • A. Market Analysis
    • Current and Future Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 56: Rest of Europe Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 57: Rest of Europe Historic Review for Immunoassay Systems by Product Segment - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 58: Rest of Europe 15-Year Perspective for Immunoassay Systems by Product Segment - Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Market Highlights.....
      • Growing In-Vitro Diagnostics (IVD) Market Fuels the Demand for Immunoassay Instruments in Asia
      • Product Registration: A Major Roadblock
      • Distribution: A Major Challenge
    • Review of Select Asian Markets
      • China
      • Chinese Market for Diagnostic Products....
      • Influencing Forces
      • Market Characteristics
      • Competitive Analysis
      • Strategies
      • End-User Analysis
      • Hospitals
      • Laboratories
      • General Population
      • Difficulties Posed by the Market
      • Distribution Channels
      • India
      • Overview
      • Immunoassays - Market Drivers
      • Emerging Trends in the Indian Immunodiagnostics Market
      • Key Statistics
    • Table 59: Indian Immunochemistry Instruments & Reagents Market (2011): Percentage Share Breakdown of Revenue by Segment (includes corresponding Graph/Chart)
    • Table 60: Indian Immunochemistry Instruments and Reagents Market (2011): Percentage Share Breakdown of Dollar Sales by Segment (includes corresponding Graph/Chart)
    • Table 61: Indian Immunoassay Reagent Market (2011): Percentage Share Breakdown of Revenue by Reagent Type (includes corresponding Graph/Chart)
      • Indonesia
      • Malaysia
      • Health Care Services - A Review
      • A Potential Market for Immunoassays
      • Singapore
      • Clinical Laboratory Equipment Market in Singapore....
      • Market Characteristics
      • Imports Scene
      • Distribution
      • End-User Analysis
      • Philippines
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 62: Asia Pacific Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 63: Asia Pacific Historic Review for Immunoassay Systems by Product Segment - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 64: Asia Pacific 15-Year Perspective for Immunoassay Systems by Product Segment - Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • Market Analysis
    • Table 65: Latin American Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 66: Latin America Historic Review for Immunoassay Systems by Product Segment - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 67: Latin American 15-Year Perspective for Immunoassay Systems by Product Segment - Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2004, 2011 & 2018 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Show More
Pricing
Get Notified
Email me when related reports are published